Patents by Inventor Fei-Fei Liu

Fei-Fei Liu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition and methods for regulating extracellular matrix accumulation
    Patent number: 11819535
    Abstract: There is described herein methods of treating a disease associated with extracellular matrix (ECM) in a patient. In some cases, the methods comprise administering to the patient a therapeutically effective amount of fibroblasts which express CD36.
    Type: Grant
    Filed: June 14, 2019
    Date of Patent: November 21, 2023
    Assignee: UNIVERSITY HEALTH NETWORK
    Inventors: Fei-Fei Liu, Xiao Zhao, Kenneth W. Yip
  • COMPOSITION AND METHODS FOR REGULATING EXTRACELLULAR MATRIX ACCUMULATION
    Publication number: 20190381133
    Abstract: There is described herein methods of treating a disease associated with extracellular matrix (ECM) in a patient. In some cases, the methods comprise administering to the patient a therapeutically effective amount of fibroblasts which express CD36.
    Type: Application
    Filed: June 14, 2019
    Publication date: December 19, 2019
    Inventors: Fei-Fei LIU, Xiao ZHAO, Kenneth W. YIP
  • Sensitizing agents for cancer therapy, methods of use and methods for the identification thereof
    Patent number: 8637481
    Abstract: There is provided herein methods, compounds and methods for identifying compounds, for sensitizing a subject with cancer to a cancer therapy by inhibiting or down-regulating UROD.
    Type: Grant
    Filed: April 12, 2010
    Date of Patent: January 28, 2014
    Assignee: University Health Network
    Inventors: Fei-Fei Liu, Emma Ito, Inki Kim
  • SENSITIZING AGENTS FOR CANCER THERAPY, METHODS OF USE AND METHODS FOR THE IDENTIFICATION THEREOF
    Publication number: 20120094900
    Abstract: There is provided herein methods, compounds and methods for identifying compounds, for sensitizing a subject with cancer to a cancer therapy by inhibiting or down-regulating UROD.
    Type: Application
    Filed: April 12, 2010
    Publication date: April 19, 2012
    Applicant: University Health Network
    Inventors: Fei-Fei Liu, Emma Ito, Inki Kim